Inflammation is a pathogenic factor for target-organ damage (TOD) in hypertension. This study examined the relationship between inflammatory parameters and urinary albumin excretion (UAE) in prehypertension. A total of 65 prehypertensive subjects (blood pressure (BP) 120 --139/80 --89 mm Hg) and 26 healthy volunteers with BP o120/80 mm Hg were included. High-sensitivity C-reactive protein (hs-CRP), and serum and urinary tumor necrosis factor-a (TNF-a) were measured as inflammatory markers. Prehypertensive individuals had higher levels of inflammatory parameters and UAE than healthy subjects. Analyses carried out in prehypertensive participants showed that BP was similar between individuals with normoalbuminuria or microalbuminuria (MAB) (UAE between 30 and 299 mg per day). However, serum hs-CRP and urinary TNF-a excretion were higher in prehypertensives with MAB. Multiple regression analysis showed that systolic blood pressure (r ¼ 0.29, Po0.01), hs-CRP (r ¼ 0.20, Po0.001), and urinary TNF-a (r ¼ 0.69, Po0.001) were independently correlated with UAE (adjusted R 2 ¼ 0.73, Po0.001). Finally, logistic regression analysis performed in the prehypertensive group with the absence or presence of MAB as the dependent variable demonstrated that hs-CRP (3.92 (1.45 --10.58), P ¼ 0.007) and urinary TNF-a (1.69 (1.20 --2.37), P ¼ 0.002) were independent risk factors for the presence of MAB. Inflammatory parameters are significantly and independently associated with UAE in prehypertensive subjects, suggesting that inflammation may be a pathogenic factor for the early vascular or TOD in these individuals.
INTRODUCTION
The European Society of Hypertension --European Society of Cardiology (ESH --ESC) guidelines 1 and the guidelines of the Joint National Committee-7 (JNC-7) from the United States of America (USA) 2 define arterial hypertension as a systolic blood pressure (SBP) X140 mm Hg and/or a diastolic blood pressure (DBP) X90 mm Hg, whereas a BP o120/80 mm Hg is defined as optimal BP by the ESH --ESC and as normal BP by the JNC-7. The non-hypertensive BP level between 120 --139 mm Hg SBP and 80 --90 mm Hg DBP has been associated with a high risk of developing hypertension, and focuses attention on a segment of the population with a higher-than-normal cardiovascular disease (CVD) risk. 3 While the JNC-7 defined this range of BP as prehypertension, 2 the ESH establishes two categories: normal BP (SBP 120 --129 mm Hg and/or DBP 80 --84 mm Hg) and normal --high BP (SBP 130 --139 mm Hg and/or DBP 85 --89 mm Hg). 1 Hypertension is a major risk factor for an array of cardiovascular and related diseases, as well as for vascular injury and/or dysfunction of different organs. Target-organ damage (TOD) in hypertension is a complex multifactorial process with the participation and interrelation of different biological systems. 4 Subclinical organ lesion related to increased BP is of great relevance as an intermediate stage in the continuum of vascular disease, and as a determinant of total cardiovascular risk. Hypertension-related subclinical renal damage is based on the finding of microalbuminuria (MAB), an integrated marker of cardiovascular risk, and a predictor of cardiac and vascular abnormalities. 5, 6 In prehypertensive patients, a significantly higher prevalence of MAB has been reported as compared with patients with a BP o120/80 mm Hg. 7, 8 Nowadays, accumulating data indicate that immunological and inflammatory mechanisms, and specifically a chronic low-grade inflammatory state, have been related to the development and pathophysiology of hypertension. 9, 10 Furthermore, inflammation may participate in the pathogenesis of early TOD in essential hypertension, with special relevance for inflammatory cytokines. 11, 12 Serum levels of inflammatory markers have been shown to be elevated in prehypertensive subjects, suggesting that prehypertension might be a proinflammatory condition contributing to the magnification of cardiovascular risk. 13, 14 However, limited evidence is available in the clinical setting about the potential implications of inflammation to MAB in the range of BP below the hypertensive level. Based on our previous findings on the independent relationship between tumor necrosis factor-a (TNF-a) and MAB in newly diagnosed patients with essential hypertension, we aimed to investigate the relationship between inflammatory parameters (high-sensitivity C-reactive protein (hs-CRP), and serum and urinary TNF-a) and UAE in subjects with prehypertension.
MATERIALS AND METHODS

Study design
Inflammatory parameter concentrations were compared between prehypertensive subjects with normoalbuminuria and prehypertensive subjects with MAB in a cross-sectional design. In addition, a comparison between prehypertensive individuals and healthy controls was performed. A careful medical history was obtained for all participants. BP, biochemical profile, inflammatory parameters and UAE were assessed.
Subjects
Eligibility criteria for inclusion were: male and female subjects with prehypertension (defined as a BP level between 120 --139 mm Hg SBP and 80 --90 mm Hg DBP); age between 40 and 65 years; non-smokers; absence of diabetes mellitus; and an estimated glomerular filtration rate 480 ml min À1 per 1.73 m 2 calculated using the Abbreviated Modification of Diet in Renal Disease Study Equation.
15 Exclusion criteria included history of any clinical manifestations of CVD (coronary artery disease, cerebral vascular disease, peripheral vascular disease and/or heart failure) or chronic respiratory, hepatic or inflammatory disease; an intercurrent acute inflammatory or infectious process and any other clinicallysignificant concurrent medical condition, including dyslipidemia and hyperuricemia; the presence of macroalbuminuria (defined as an UAE 4 300 mg per day); history of alcohol and/or drug abuse; and treatment in the previous 3 months with glucocorticoids or any other drug with antiinflammatory properties (including statins, aspirin and pentoxifylline).
Two-hundred and sixty-seven individuals were initially evaluated ( Figure 1 ). Finally, the study population consisted of 65 subjects with prehypertension that fulfilled the above criteria, and 26 healthy volunteers who were age-, body mass index-and sex-matched, with a BP lower than 120/80 mm Hg, which were recruited from the Primary Health Care Community Program. All individuals had no history of treatment with antihypertensive drugs. The protocol was in accordance with the Declaration of Helsinki and was approved by the institutional committee, and all subjects gave their informed consent.
Anthropometrics and BP
Weight and height were measured by standard techniques and body mass index was calculated as body weight divided by the square of height in meters. Arterial BP was measured using a mercury sphygmomanometer by the same observer with the patient in the sitting position after 10 min of rest. Three readings separated by 2 min were taken, and the average was used for calculation. The first and fifth phases of Korotkoff sounds were used to define SBP and DBP, respectively. Subjects who had a mean SBP/ DBP within the range of 120 --139/80 --89 mm Hg were defined as prehypertensive according to the JNC-7. 2 In addition, according to the ESH, 1 participants were classified as having normal BP, defined as a SBP 120 --129 mm Hg and/or DBP 80 --84 mm Hg, and normal --high BP, defined as a SBP 130 --139 mm Hg and/or DBP 85 --89 mm Hg, respectively.
Laboratory measurements
Blood samples were drawn before breakfast in the morning, after an overnight fast. After collection, samples were centrifuged at 3000 g for 10 min, and then stored at À80 1C until assayed. The glucose level was measured by an automated enzymatic method. The concentration of hs-CRP was measured by an ultrasensitive competitive immunoassay (interassay coefficient of variation of 8.4%) (Calbiochem, La Jolla, CA, USA). Serum and urinary concentrations of TNF-a were measured by a highsensitive, solid-phase, chemiluminescent immunometric assay. The analytical sensitivity was similar for the urinary and serum determinations (1.7 pg ml À1 ), and the intra-and inter-assay coefficients of variability were 3.6% and 4.4%, respectively.
For the purpose of the study, UAE was determined by a 24-h urine collection and expressed as mg per day. However, all participants had at least two previous rounds of determination of the albumin-to-creatinine ratio in a first voided morning urine sample, which showed a close association with the 24-h UAE. Urinary albumin was quantified by immunoturbidimetry (coefficient of variation 5.5%). Normoalbuminuria was considered when UAE rate was o30 mg per 24 h, and MAB was defined as a UAE rate of 30 --299 mg per 24 h. (MAB indicates amounts of UAE greater than the 95% confidence interval of the normal population but less than amounts detectable by classical semiquantitative methods (urine dipstick).) 16 Urinary TNF-a levels were related to the concomitant urinary creatinine concentration content in order to compensate for variations in urinary concentration, and are expressed as pg mg À1 .
Statistical analysis
Based on previous data from our unit, an s.d. of 2.10 pg mg À1 for urinary TNF-a concentration was obtained in subjects with a BP between 120 --129/80 --89 mm Hg. Accordingly, a sample size calculation showed that, to detect a 30% relative difference in the urinary concentration of TNF-a between prehypertensive subjects with and without MAB, at least 29 prehypertensive subjects for each group would be adequate, with a statistical power 490% at the 5% probability level.
Results are expressed as mean values±s.d., except for UAE, hs-CRP and TNF-a, which are presented as median and interquartile range. Serum and urinary levels of TNF-a, hs-CRP and UAE were logarithmically transformed for statistical analyses and then back-transformed to their natural units for presentation in tables and figures. Statistical comparisons among groups were performed by Student's t-test for independent samples or analysis of variance with Bonferroni correction. Simple correlation analysis was performed using Pearson's correlation. Partial correlation analysis was performed to determine the extent to which a relationship was altered after adjusting for the other variables. A forward stepwise multiple regression analysis was performed to determine the independent association between diverse independent variables (gender, age, SBP and DBP, body mass index, serum glucose, uric acid, estimated GFR, hs-CRP and serum and urinary TNF-a) and UAE as the dependent variable. Finally, to assess the contribution of inflammatory parameters to MAB, multiple logistic regression analysis was performed in the absence/presence of MAB as the dependent variable with the independent variables as listed above. Colinearity was excluded by the analysis of the eigen value. A P-value o0.05 was considered to be statistically significant. Statistical analyses were conducted with SPSS 17.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Two hundred and sixty seven prehypertensive subjects aged between 40 and 65 years were initially screened, of which 202 subjects were excluded because they either did not meet the inclusion criteria or met the exclusion criteria (57 had diabetes mellitus, 43 had CVD, 32 had dyslipidemia, 26 had eGFR o80 ml min À1 per 1.73 m 2 , 19 had hyperuricemia, 9 presented with macroalbuminuria, 6 had chronic respiratory disease, 6 were treated with drugs with anti-inflammatory properties, 2 had an acute infectious process; and 2 owing to alcoholic abuse). Thus, 65 prehypertensive subjects were finally included in the study. Table 1 gives the demographic and laboratory data of healthy control subjects and individuals with prehypertension. Besides SBP and DBP, prehypertensive individuals had significantly higher UAE, as well as a higher concentration of inflammatory parameters in comparison with individuals with a BP o120/80 mm Hg. Comparative data of prehypertensive subjects classified according to the ESH criteria are represented in Table 2 . As compared with subjects with optimal BP, UAE was higher in individuals with normal (P ¼ 0.06) and normal --high BP (Po0.001). Likewise, albuminuria was also significantly higher in subjects with normal --high BP than in those with normal BP (Po0.05). None of the subjects with optimal BP presented an increased UAE, whereas MAB was observed in 31 out of the 65 prehypertensive subjects, without any difference between individuals with normal BP and normal --high BP. Concerning the inflammatory parameters, individuals with normal --high BP showed significantly higher concentrations of hs-CRP as well as serum and urinary TNFa than subjects with optimal BP. However, as compared with the participants with normal BP, only hs-CRP showed significantly higher levels. Interestingly, there were no significant differences between subjects with optimal and normal BP regarding hs-CRP and serum TNF-a. The only difference between these groups was the elevated urinary excretion of TNF-a observed in individuals with normal BP (Po0.05).
A comparative analysis of prehypertensive individuals classified according to UAE is shown in Table 3 . There were no significant differences in BP between normoalbuminuric and microalbuminuric subjects. However, the serum levels of hs-CRP and the urinary excretion of TNF-a were significantly higher in prehypertensive individuals with MAB, without significant differences regarding serum TNF-a concentration (Figure 2 ). In addition, when subjects with prehypertension were divided into two groups, based on the level of hs-CRP (high CRP43 mg l À1 versus low CRPp3 mg l À1 , according to the recent statement from the Centers for Disease Control and Prevention and the American Heart Association), 17 individuals with a hs-CRP 43 mg l À1 had a significantly higher UAE as well as higher serum and urinary TNF-a concentrations. No differences were observed regarding BP levels (Table 4) .
Correlation analysis among inflammatory parameters in prehypertensive subjects showed that hs-CRP was significantly related to serum (r ¼ 0.29, Po0.05) and urinary TNF-a (r ¼ 0.38, Po0.05), whereas serum TNF-a was only related to hs-CRP. Interestingly, there was no other significant relationship between the serum concentration and the urinary excretion of TNF-a. Unadjusted correlation analysis showed that UAE was significantly correlated with SBP (r ¼ 0.27, Po0.05), serum concentration of hs-CRP (r ¼ 0.53, Po0.01) and urinary excretion of TNF-a (r ¼ 0.75, Po0.001). After adjusting for the effect of other variables by partial correlation analysis, only the previous associations between UAE and hs-CRP (r ¼ 0.40, Po0.01) and urinary TNF-a (r ¼ 0.69, Po0.001) remained significant. We did not find any significant correlation among these variables when this analysis was performed in the group of healthy subjects with optimal BP. Inflammation and microalbuminuria in prehypertension JF Navarro-González et al
Forward stepwise multiple regression analysis in prehypertensive subjects was performed using UAE as the dependent variable. The results showed that, from the different independent variables included in the analysis, SBP, hs-CRP and urinary TNF-a were independently correlated with UAE (adjusted R 2 ¼ 0.73, Po0.001) ( Table 5 ). In order to evaluate whether inflammation was associated with a higher risk of MAB, multiple logistic regression analysis using the absence/presence of MAB as the dependent variable was performed. The results showed that hs-CRP (3.92 (1.45 --10.58), P ¼ 0.007) and urinary TNF-a (1.69 (1.20 --2.37), P ¼ 0.002) were independent risk factors for the presence of MAB in individuals with prehypertension (Table 6 ). Finally, logistic regression was performed when all participants were entered into the analysis, which showed that prehypertension was not an independent predictor of MAB.
DISCUSSION
The main findings of the present study are that prehypertensive individuals with MAB showed significantly elevated levels of inflammatory parameters than subjects with normoalbuminuria and, furthermore, when albuminuria was considered as a continuous variable, UAE was positive, significant and independently associated with hs-CRP and urinary, but not serum TNF-a. Moreover, logistic regression analysis demonstrated that elevated levels of hs-CRP and urinary TNF-a are independent risk factors for the presence of MAB in prehypertension. These findings suggest that inflammation may be an important factor in the development of MAB and early vascular lesion in prehypertensive patients.
Increasing evidence has accumulated regarding the role of a chronic low-grade subclinical inflammation as a pathogenic factor in diseases that are classically considered as non-inflammatory conditions, such as type 2 diabetes mellitus and diabetic nephropathy. 18, 19 Likewise, the involvement of inflammation in the development and pathophysiology of hypertension has been highlighted. 9, 10 Previous studies have revealed an association between prehypertension and inflammatory markers, suggesting that prehypertension might be a proinflammatory condition. The ATTICA Study, a cross-sectional population-based survey including 1188 prehypertensive subjects, demonstrated that serum levels of CRP and TNF-a were significantly elevated in prehypertension compared with normotensive subjects. 13 In addition, the Third National Health and Nutrition Examination Survey showed that prehypertensive participants had a significantly higher prevalence of elevated CRP than normotensive people, an association that remained significant and independent after adjustment for different factors. 20 On the contrary, the Multi-Ethnic Study of Atherosclerosis showed that prehypertensive individuals had CRP values similar to those for subjects with BP o120/80 mm Hg. 21 All these studies included participants with other conditions that could potentially influence the presence of inflammation and the level of inflammatory markers, such as diabetes, hypercholesterolemia, smoking or anti-inflammatory drugs. In our study, in order to avoid potential Abbreviations: hs-CRP, hs-C-reactive protein; TNF-a, tumor necrosis factor-a. Abbreviation: TNF-a, tumor necrosis factor-a.
Inflammation and microalbuminuria in prehypertension JF Navarro-González et al confounding factors, subjects with any significant intercurrent condition (including CVD, renal failure, diabetes, dyslipidemia, hyperuricemia, smoking habit, or treatment with antihypertensives or any other drug with anti-inflammatory effects) were excluded, and, similarly to the ATTICA Study, we found that prehypertensive subjects had significantly higher serum levels of hs-CRP and TNF-a. In addition, we observed that urinary TNF-a concentration was also increased in these individuals. MAB is more frequent in subjects with prehypertension than in subjects with normal BP. Lee et al. 22 observed that the prevalence of MAB was 7.9% in prehypertensive subjects, as compared with 4% in normotensive individuals. More recently, data from the National Health and Nutrition Examination Survey showed that the prevalence of MAB was 4.5% for normal BP and 6.3% for prehypertension, and those subjects with prehypertension had a significant 30% higher risk for the presence of MAB. 23 On the contrary, Norton et al. 24 reported that after adjustment for different confounders, prehypertension was not associated with indexes of organ changes. In that work, a significant proportion of participants had relevant associated conditions, including overweight, obesity, regular tobacco use, alcohol intake, DM or elevated glycated hemoglobin. In the present study, prehypertensive subjects had a sevenfold increase in the mean UAE level compared with individuals with a BP o120/80 mm Hg, whereas participants with normal--high BP had a higher UAE than subjects with normal BP or optimal BP. Likewise, UAE was also higher in individuals with normal BP than in those with optimal BP, with a difference that almost reached statistical significance (P ¼ 0.06). These results are in agreement with the recent findings by Kim et al., 25 who observed that UAE and prevalence of MAB were higher in individuals with normal--high BP than in subjects with normal BP. In that study, subjects with diabetes, CVD, renal disease, inflammatory processes, tumors and proteinuria were excluded. Therefore, our findings and those by Kim et al. suggest that prehypertension per se, especially BP in the normal --high range, is associated with increased UAE and a higher prevalence of MAB.
Hypertension-induced TOD is the result of a complex network with the participation of inflammation. Elevation of inflammatory markers has been related to a greater chance of having at least one preclinical cardiovascular abnormality. 26 In addition, hypertensive patients with TOD have higher serum concentrations of hs-CRP and TNF-a than hypertensives without TOD, with an independent association between subclinical markers of CVD and inflammatory parameters. 27 We previously reported that hs-CRP and urinary TNF-a were independent determinants of the presence of MAB in essential hypertension. 11 However, to our knowledge, there are no previous studies regarding the association between inflammation and MAB in prehypertensive subjects.
In a sense, the kidney (the glomerular capillary) is the window of the systemic vasculature, albumin leakage into the urine is a reflection of widespread vascular damage and increased permeability of albumin through the vascular wall is considered to be a marker of endothelial dysfunction. This relationship is supported by different studies, not only in high-risk populations but also in cohorts with clinically healthy subjects, that found that brachial artery flow-dependent dilation was significantly impaired in healthy individuals with MAB as compared with those with normoalbuminuria. Therefore, MAB is a reflection of endothelial vascular dysfunction, an alteration that, as has been suggested, may promote the development of hypertension. 31 Several studies have shown a relationship between prehypertension, alterations in microvascular physiology and endothelial dysfunction. Erdogan et al. 32 showed that coronary flow reserve was impaired in prehypertensive individuals compared with normotensive subjects, demonstrating that mildly elevated BP was associated with alterations in coronary microvascular function. More recently, Giannotti et al. 33 demonstrated that, as compared with healthy subjects, in vivo endothelial repair capacity of early endothelial progenitor cells was reduced in prehypertensive subjects having prehypertension as the only cardiovascular risk factor, and, moreover, this alteration was significantly related to impaired endothelial function. In the present study, prehypertensive individuals with MAB presented higher serum hs-CRP levels than subjects with normal UAE, whereas serum TNF-a concentrations were similar. On the contrary, urinary TNF-a excretion was significantly elevated in microalbuminuric prehypertensive individuals. Furthermore, along with SBP, hs-CRP and urinary TNF-a were independently associated with UAE, and, moreover, logistic regression analysis demonstrated that hs-CRP and urinary TNF-a were independent risk factors for the presence of MAB in subjects with prehypertension. Therefore, inflammation may be a pathogenic factor in the development of endothelial dysfunction in prehypertension, subsequently leading to increased UAE and MAB.
TNF-a is a pro-inflammatory cytokine with significant deleterious effects on the endothelium, including impairment of nitric-oxide bioavailability, increment of oxidative stress and susceptibility to oxidant injury, and induction of endothelial cell apoptosis. 34 In addition, this cytokine is able to induce renal damage through different bioactivities, including hemodynamic alterations, disruption of glomerular permeability barrier, procoagulant effects, recruitment of infiltrating cells into the kidney and induction of apoptosis. 35, 36 In our study, there was no significant relationship between serum and urinary TNF-a, indicating that urinary excretion of TNF-a was not dependent on the serum levels of this cytokine, strongly suggesting an intra-renal production of TNF-a. These findings are in agreement with previous works that have demonstrated that there is no correlation between serum and TNF-a content in target organs, including the heart and kidney, 37, 38 and that the biological effects of this cytokine correlate with intra-organ, but not with peripheral TNF-a levels. 38, 39 Finally, when the participants in our study were classified according to the ESH --ESC criteria, subjects with normal --high BP had significantly higher UAE and higher levels of inflammatory parameters than subjects with optimal BP. Importantly, higher levels of UAE and hs-CRP were observed in individuals with normal BP than in those with optimal BP, although the differences showed a marginal significance. However, apart from the BP values, the only difference between the optimal and normal BP groups was related to the urinary TNF-a excretion, which was higher in individuals with normal BP. This suggests that mild BP increase above the optimal level, even within the normal range, may be associated with a local low-grade inflammatory reaction in target organs, which may precede any significant systemic evidence of inflammation (that is, an increase of hs-CRP), as well as increased UAE and MAB, suggesting that inflammation may be directly related to the development of early organ and vascular damage in prehypertension.
A relevant strength of the present study is the lack of interference of potential confounders such as intercurrent conditions and treatments potentially affecting inflammation and UAE. On the other hand, this study should be evaluated in the context of several limitations. First, although a previous sample-size calculation was performed and the number of participants was sufficient to perform the analysis, the sample size is relatively small, which may have prevented some of the detected associations from being statistically significant. In addition, it may be risky to extrapolate these findings to the large population of individuals with prehypertension. Second, the age range of participants in the present study was 40 --65 years (middle age); therefore, with the aging population, information on the relationship between inflammation and MAB among elderly subjects would be pertinent. Third, despite that inflammatory parameters were measured at the same time point as UAE, and in spite of having adjusted for confounders, the cross-sectional nature of the study does not permit to determine an absolute cause-and-effect relationship. However, it is possible to hypothesize about a possible mechanistic explanation for the nature of the detected associations.
Hypertension has been classically considered as a major determinant of TOD, with inflammation acting as a downstream phenomenon, promoting inflammatory activation of endothelium, recruitment of inflammatory cells, and activation of recruited and organ resident cells, with increase of inflammatory markers as the final consequence. 40 Experimental works have indicated that inflammatory molecules (including inflammatory cytokines) are able to promote detrimental effects on vessels and target tissues. 41 Regarding prehypertension, it has been demonstrated that even a mild elevation of BP above the optimal range is closely related to rheologic, hemodynamic and metabolic abnormlities, 42 and, likewise, it is possible to speculate that this mild increase of BP, through a sustained hemodynamic overload with key participation of mechanical and humoral factors, may induce a local inflammatory reaction with a critical role in the pathogenesis of silent vascular damage and organ lesion. 43, 44 In conclusion, inflammatory parameters are significantly elevated in subjects with prehypertension, and, among them, these parameters are higher in those with MAB than in normoalbuminuric subjects. Furthermore, UAE is positive, significant and independently associated with hs-CRP and urinary TNF-a; moreover, these parameters are independent risk factors for the presence of MAB. Importantly, although UAE and hs-CRP were marginally elevated in individuals with normal BP compared with those with optimal BP, the only significant difference between both groups was the higher excretion of urinary TNF-a in subjects with normal BP.
What is known about this topic
Subclinical target organ damage related to increased blood pressure is a determinant of total cardiovascular risk. Hypertension-related subclinical renal damage is based on the finding of microalbuminuria (MAB), which is, in addition, an integrated marker of cardiovascular risk and a predictor of cardiac and vascular abnormalities. Chronic low-grade inflammation has been related to the development and pathophysiology of hypertension, as well as to the pathogenesis of early target organ damage in essential hypertension. Serum levels of inflammatory markers have been shown to be elevated in prehypertensive subjects, suggesting that prehypertension might be a pro-inflammatory condition contributing to the magnification of cardiovascular risk.
What this study adds
Prehypertensive subjects have elevated levels of inflammatory parameters and urinary albumin excretion as compared with individuals with optimal blood pressure. Furthermore, whereas blood pressure was similar between prehypertensive individuals with normoalbuminuria or microalbuminuria, the levels of inflammatory parameters were higher in prehypertensives with microalbuminuria. Inflammatory parameters are direct, significant and independently associated with urinary albumin excretion in prehypertensives. In addition, increased levels of inflammatory parameters is an independent risk factor for the presence of microalbuminuria in prehypertensive subjects. Inflammation may be a pathogenic factor for the early vascular/ target organ damage in prehypertensive individuals.
